Not investment advice.Read full disclaimer
Continue with finqOS
Side-by-side valuation, growth, and profitability metrics against the closest competitors.
14-day free trial · No credit card required
52W Range
Volume
Mkt Cap
P/E
Div Yield
Publicly traded Dr. Reddy's Laboratories Limited (DRREDDY.NS) competitors and peer companies. Compare valuation, revenue growth, margins, and profitability against Cipla Limited, Zydus Lifesciences Limited, Zydus Lifesciences Limited, Lupin Limited, Lupin Limited, and more.
| Ticker | Company | Market Cap |
|---|---|---|
| CIPLA.NS | Cipla Limited | $1.19T |
| ZYDUSLIFE.BO | Zydus Lifesciences Limited | $1.13T |
| ZYDUSLIFE.NS | Zydus Lifesciences Limited | $1.12T |
| LUPIN.BO | Lupin Limited | $1.11T |
| LUPIN.NS | Lupin Limited | $1.11T |
| MANKIND.NS | Mankind Pharma Limited | $1.05T |
| MANKIND.BO | Mankind Pharma Limited | $1.04T |
| AUROPHARMA.NS | Aurobindo Pharma Limited | $901.6B |
| AUROPHARMA.BO | Aurobindo Pharma Limited | $900.1B |
| ALKEM.NS | Alkem Laboratories Limited | $656.2B |